首页> 外国专利> TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES

TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES

机译:NA +,K + -ATPase的Alpha-1或Alpha-3亚基在治疗增生性疾病中的作用

摘要

Targeting of select subunits of the Na+,K+-ATPase is described, and especially the alpha-1 subunit and/or the alpha-3 subunit. Antisense agents, agents capable of causing RNA interference that can reduce the expression of Na+,K+-ATPase, and antibodies and antibody fragments and derivatives specific for Na+,K+-ATPase are useful as reagents and pharmaceutical formulations for the treatment of proliferative diseases, such as tumours and cancers. Methods and kits are also described.
机译:描述了靶向Na +,K + -ATP酶的选择亚基,尤其是α-1亚基和/或α-3亚基。反义剂,能够引起RNA干扰的可降低Na +,K + -ATP酶表达的试剂,以及对Na +,K + -ATP酶特异的抗体和抗体片段以及衍生物,可用作治疗增生性疾病的试剂和药物制剂,例如作为肿瘤和癌症。还介绍了方法和试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号